Damascus, SANA- Syrian Investment Authority has granted an investment license for a human medicine manufacturing project in Adra Industrial City, Damascus countryside, with an estimated value of 24 billion Syrian pounds.
The project’s annual production capacity is 30 million capsules of soft gelatin, 2.4 million ointment tubes, 120 million tablets, 168 million capsules, 1.8 million oral single doses in plastic containers and 3.2 million syrup packages.

100 job opportunities are expected to be provided by this project.

Fedaa al-Rahai